Gene Therapy Restores Partial Vision in Blind Patients, Basel Study Shows

Researchers in Basel report a breakthrough gene therapy that has given blind patients their first visual impressions. The therapy's efficacy is claimed, but details on patient numbers, durability, and safety remain limited. This marks a potential milestone in ophthalmology, though broader clinical validation is pending.